Article
IL20RB promotes pancreatic cancer progression by activating NF- kB signalling and promoting EMT
2025-02-04
Abstract excerpt
<title>Abstract</title> <p><bold>Purpose </bold>Currently, the pathogenesis and biological features of pancreatic cancer are not fully understood. Interleukin-20 receptor subunit beta (IL20RB) is a risk factor for poor prognosis in a variety of solid tumours, including breast cancer. However, the biological characteristics of IL20RB in pancreatic cancer and its impact on patient prognosis remain unclear. The aim...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5823a93c-47ff-5deb-ac84-5b3824d54d4c
- DOI
- 10.21203/rs.3.rs-5929013/v1
